Healthcare -
Biotechnology - NASDAQ - US
$ 42.5681
0.355 %
$ 11.6 B
Market Cap
19.26
P/E
EXEL - OPERATING INCOME
Operating Income EXEL - Exelixis, Inc.
605 M
LAST VALUE
73.23%
2 YEAR CAGR
10.35%
5 YEAR CAGR
16.72%
10 YEAR CAGR